Platelet aggregation and coagulation factors in orthopedic surgery
Brandon S Oberweis1, Germaine Cuff, Andrew Rosenberg
1Department of Medicine, New York University Langone Medical Center, 530 First Avenue Skirball 9R, New York, NY, 10016, USA.
Journal of Thrombosis and Thrombolysis
|May 31, 2014
Summary
Perioperative hemostasis involves dynamic changes in platelet aggregation and coagulation factors. Platelet activity and coagulation markers decrease intraoperatively, then increase postoperatively, potentially impacting bleeding or thrombosis risk.
Area of Science:
- Anesthesiology and Perioperative Medicine
- Hematology
- Surgical Research
Background:
- Hemostasis is critical during surgery, with altered platelet aggregation and coagulation factors potentially influencing thrombosis and bleeding risks.
- Understanding perioperative hemostatic changes is crucial for managing patient safety.
Purpose of the Study:
- To investigate dynamic changes in platelet aggregation and specific coagulation factors (Factor VII, Factor VIII, von Willebrand Factor, fibrinogen) during the perioperative period.
- To elucidate the hemostatic balance shifts that may contribute to perioperative complications.
Main Methods:
- Prospective cohort study of 70 patients undergoing non-emergent orthopedic surgery (knee, hip, spine).
- Plasma samples collected at five time points: preoperatively, intraoperatively, and 1, 24, and 48 hours postoperatively.
- Assessed platelet function using whole blood impedance aggregometry and measured coagulation factors (FVII, FVIII, vWF, fibrinogen).
Main Results:
- Platelet activity decreased intraoperatively, then significantly increased above baseline at 24 and 48 hours postoperatively.
- Coagulation factors decreased intraoperatively; Factor VII activity continued to decline, while FVIII, vWF, and fibrinogen levels rose postoperatively.
- Observed significant perioperative alterations in both platelet function and coagulation factor levels.
Conclusions:
- Significant changes in platelet activity and coagulation factors occur during the perioperative period.
- These hemostatic shifts, characterized by intraoperative decreases and postoperative increases in certain markers, may underlie perioperative hypercoagulability or bleeding risks.
- Further research correlating these hemostatic changes with clinical outcomes is warranted.
Related Concept Videos
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
Introduction to Hemostasis
Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized, and...
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized, and...
Formation of the Platelet Plug
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
Coagulation
The coagulation phase is a critical part of the body's process to prevent blood loss following injury to blood vessels. It involves chemical reactions that form a clot to seal the injured area. The clotting process begins shortly after injury, within 15-20 seconds for severe damage and 1-2 minutes for minor injuries.
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
Extrinsic and Intrinsic Pathways of Hemostasis
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...
Clot Retraction and Fibrinolysis
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.


